Bharat Biotech finds Covaxin 81pc efficient in Phase 3 trials
siasat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from siasat.com Daily Mail and Mail on Sunday newspapers.
Bharat Biotech s Covaxin 81pc efficient in Phase 3 trials
yourstory.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yourstory.com Daily Mail and Mail on Sunday newspapers.
Coronavirus: Citizens above 60, those above 45 with comorbidities to be vaccinated from March 1
The vaccines will be given at 10,000 government centres and 20,000 private inoculation facilities. Updated Feb 24, 2021 · 08:12 pm A photo of Union minister Prakash Javadekar addressing the media on Wednesday. | Screenshot/PIB via YouTube
Union minister Prakash Javadekar on Wednesday announced that the Centre will begin vaccinating citizens who are above the age of 60 and those above 45 deemed at high-risk because of pre-existing medical conditions, from March 1, ANI reported.
The vaccines will be given at 10,000 government centres and 20,000 private inoculation centres, he said. The shots given at the public centres will be free of cost.
Updated Feb 23, 2021 · 05:17 pm A health worker takes a swab sample of a woman for conducting RT-PCR test in Chennai on February 22. | Arun Sankar/ AFP
India on Tuesday registered 10,584 new coronavirus cases, taking the overall count to 1,10,16,434. Seventy-eight more deaths pushed the country’s toll to 1,56,463.
The number of active cases stood at 1,47,306, while the number of recoveries reached 1,07,12,665. As many as 1,17,45,552 health care and frontline workers have been vaccinated against the coronavirus so far. Of these, 6,28,696 were inoculated on Monday.
India is using two vaccines, the Oxford University/AstraZeneca vaccine produced by the Serum Institute in Pune, and a government-backed vaccine developed by Hyderabad-based Bharat Biotech whose efficacy is not entirely yet known.